Cargando…

Tocilizumab and COVID-19: Timing of Administration and Efficacy

Elevated concentrations of interleukin-6 have been demonstrated to be an important key factor in COVID-19 host immune impairment. It represents an important prognostic factor of harm associated with COVID-19 infection by stimulating a vigorous proinflammatory response, leading to the so-called “cyto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abidi, Emna, El Nekidy, Wasim S., Alefishat, Eman, Rahman, Nadeem, Petroianu, Georg A., El-Lababidi, Rania, Mallat, Jihad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894855/ https://www.ncbi.nlm.nih.gov/pubmed/35250575 http://dx.doi.org/10.3389/fphar.2022.825749

Ejemplares similares

Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers
por: Atallah, Bassam, et al.
Publicado: (2020)

Assessment of antibiotic appropriateness at discharge: experience from a quaternary care hospital setting
por: Saleh, Joanna, et al.
Publicado: (2022)

Sustaining Life versus Altering Life-Saving Drugs: Insights to Explain the Paradoxical Effect of Extracorporeal Membrane Oxygenation on Drugs
por: Abidi, Emna, et al.
Publicado: (2023)

Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy
por: Attallah, Nizar, et al.
Publicado: (2021)

Editorial: Advances in antimicrobial therapy and combating resistance
por: Ghazi, Islam M., et al.
Publicado: (2023)

1622. Outcomes of Colistin Weight-Based Dosing Versus The Non-Weight-Based Dosing
por: Anouassi, Zohour, et al.
Publicado: (2020)

Clinical Pharmacokinetics and Pharmacodynamics of Desmoteplase
por: Piechowski-Jozwiak, Bartlomiej, et al.
Publicado: (2021)

Thromboelastography findings in critically ill COVID-19 patients
por: Salem, Nouran, et al.
Publicado: (2020)

1189. The Impact of Clinical Staff Pharmacist Driven Weekend Antimicrobial Stewardship Coverage in a Quaternary Hospital in UAE
por: Elrefaei, Hazem, et al.
Publicado: (2023)

Outcomes of caspofungin use in the treatment of Candida-related urinary tract infections, a case series
por: Rkieh, Laila, et al.
Publicado: (2022)

Tocilizumab Use in a Chronic Hemodialysis Patient for the Management of COVID-19-Associated Pneumonia and Acute Respiratory Distress Syndrome
por: Gupta, Sudeendra, et al.
Publicado: (2020)

138. Implementation of an Antimicrobial Stewardship Order Set in the Emergency Department at a Quaternary Care Facility
por: . Al Shaqfa, Salma M, et al.
Publicado: (2021)

Ionone Is More than a Violet’s Fragrance: A Review
por: Aloum, Lujain, et al.
Publicado: (2020)

The prevalence of cardiorenal anemia syndrome among patients with heart failure and its association with all-cause hospitalizations: a retrospective single-center study from the Middle East
por: Manla, Yosef, et al.
Publicado: (2023)

Remedia Sternutatoria over the Centuries: TRP Mediation
por: Aloum, Lujain, et al.
Publicado: (2021)

Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19
por: Belladonna, Maria Laura, et al.
Publicado: (2020)

Optimizing antimicrobial therapy in urinary tract infections: A focus on urine culture and sensitivity testing
por: Alkhawaldeh, Rama, et al.
Publicado: (2022)

Tocilizumab and COVID-19: Timing of administration assessment
por: Richier, Q., et al.
Publicado: (2022)

Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6
por: Li, Pan, et al.
Publicado: (2021)

Assessment and Comparison of the Efficacy of Methotrexate, Prednisolone, Adalimumab, and Tocilizumab on Multipotency of Mesenchymal Stem Cells
por: Liu, Shuang, et al.
Publicado: (2020)

Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach
por: Ghazi, Islam M., et al.
Publicado: (2020)

Correction: Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach
por: Ghazi, Islam M., et al.
Publicado: (2020)

Efficacy and Outcome of Remdesivir and Tocilizumab Combination Against Dexamethasone for the Treatment of Severe COVID-19: A Randomized Controlled Trial
por: Mohiuddin Chowdhury, Abu Taiub Mohammed, et al.
Publicado: (2022)

Efficacy and safety of baricitinib and tocilizumab in hospitalized patients with COVID-19: A comparison using systematic review and meta-analysis
por: Cherian, Jerin Jose, et al.
Publicado: (2022)

The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study
por: Li, Sizhao, et al.
Publicado: (2021)

Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment
por: Sarabia De Ardanaz, Luis, et al.
Publicado: (2021)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Lymph Nodes-On-Chip: Promising Immune Platforms for Pharmacological and Toxicological Applications
por: Shanti, Aya, et al.
Publicado: (2021)

Characteristics of critically ill patients infected with COVID-19 in Abu Dhabi, United Arab Emirates
por: Abdallah, Khaled, et al.
Publicado: (2020)

Theoretical Study of Hydroxylation of α- and β-Pinene by a Cytochrome P450 Monooxygenase Model
por: Shaya, Janah, et al.
Publicado: (2023)

Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients
por: Rutgers, Abraham, et al.
Publicado: (2022)

Cannabidiol Inhibits Multiple Ion Channels in Rabbit Ventricular Cardiomyocytes
por: Isaev, Dmytro, et al.
Publicado: (2022)

Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial
por: El-Khateeb, Eman, et al.
Publicado: (2023)

Treatment of recurrent urinary tract infections in anuric hemodialysis patient, do we really need antimicrobial urinary concentration?
por: El Nekidy, Wasim S., et al.
Publicado: (2020)

Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone
por: Wong, Carlos K. H., et al.
Publicado: (2022)

Toxic Effects of Trichloroethylene on Rat Neuroprogenitor Cells
por: Salama, Mohamed M., et al.
Publicado: (2018)

Efficacy of Single Tocilizumab Administration in an 88-Year-Old Patient with Severe COVID-19 and a Mini Literature Review
por: Ould Ouali, Cid, et al.
Publicado: (2022)

Efficacy of tocilizumab in COVID-19: A review of the current evidence
por: Alam, Walid, et al.
Publicado: (2021)

Meningitis as the initial manifestation of systemic lupus erythematosus
por: Al Mahmeed, Nada, et al.
Publicado: (2020)

The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial
por: Dastan, Farzaneh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vbsf1u6aerfscv1mim6jbn1nb6